Urinary adiponectin excretion is an early predictive marker of the decline of the renal function in patients with diabetes mellitus.
J Diabetes Complications
; 35(4): 107848, 2021 04.
Article
em En
| MEDLINE
| ID: mdl-33558151
ABSTRACT
AIMS:
Since diabetes-associated kidney complication changes from diabetic nephropathy to diabetic kidney disease (DKD), more suitable biomarkers than urinary albumin are required. It has been hypothesized that urinary adiponectin (u-ADPN) is associated with the progression of DKD. We therefore evaluated the effectiveness of u-ADPN in predicting the decline of the renal function in patients with diabetes prior to end-stage renal disease.METHODS:
An ultrasensitive immune complex transfer enzyme immunoassay (ICT-EIA) was used to measure total and high molecular weight (HMW) adiponectin separately. We evaluated the relationships between the creatinine-adjusted urinary total-ADPN and HMW-ADPN, albumin (UACR) and liver-type fatty acid binding protein (L-FABP) at baseline and the 2-year change of the estimated glomerular filtration rate (ΔeGFR).RESULTS:
This 2-year prospective observational study included 201 patients with diabetes. These patients were divided into three groups according to their ΔeGFR ≤-10â¯mL/min/1.73m2, >-10 and ≤0â¯mL/min/1.73m2, and >0â¯mL/min/1.73m2. Jonckheere-Terpstra test showed that lower ΔeGFR was associated with higher u-HMW-ADPN (pâ¯=â¯0.045). In logistic regression analysis, u-HMW-ADPN was associated with ΔeGFR after adjusted age, sex, and basal eGFR.CONCLUSION:
Urinary HMW-ADPN could predict a declining renal function in patients with diabetes.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Nefropatias Diabéticas
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article